| scholarly article | Q13442814 |
| P2093 | author name string | Tetsuji Sawada | |
| Kosei Hirakawa | |||
| Masakazu Yashiro | |||
| Hiroshi Nakada | |||
| Mariko Ohta | |||
| Kaoru Akita | |||
| Yugo Mori | |||
| Munetoyo Toda | |||
| Akiko Ishida | |||
| Mizue Inoue | |||
| Shuhei Tanida | |||
| P2860 | cites work | Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways | Q22254056 |
| Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components | Q24312497 | ||
| Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin | Q24522854 | ||
| Siglecs in the immune system | Q24682458 | ||
| Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism | Q28114789 | ||
| The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin | Q28142359 | ||
| DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7 | Q28204499 | ||
| Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling | Q28205083 | ||
| Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland | Q28208406 | ||
| The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin | Q28210439 | ||
| MUC1, the renaissance molecule | Q28215731 | ||
| Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion | Q28237260 | ||
| Siglecs--the major subfamily of I-type lectins | Q28261393 | ||
| MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin | Q28281821 | ||
| Cell-associated episialin is a complex containing two proteins derived from a common precursor | Q28294785 | ||
| The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms | Q28566287 | ||
| Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. | Q30868758 | ||
| Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen | Q33564580 | ||
| Topology of cell adhesion molecules | Q33836280 | ||
| MUC1 is a novel regulator of ErbB1 receptor trafficking | Q34571022 | ||
| MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling | Q34572658 | ||
| Beta-catenin and the morphogenesis of colorectal cancer | Q34732468 | ||
| Cloning and sequencing of a human pancreatic tumor mucin cDNA. | Q34942577 | ||
| Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly | Q35123403 | ||
| Two categories of mammalian galactose-binding receptors distinguished by glycan array profiling | Q35545703 | ||
| Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. | Q38307814 | ||
| Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9 | Q39640710 | ||
| Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. | Q39690197 | ||
| Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells | Q39928639 | ||
| MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1. | Q39993144 | ||
| MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells | Q40498647 | ||
| MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1. | Q40550805 | ||
| Tumour-associated leucocytes: friends or foes in breast carcinoma | Q40758526 | ||
| Identification of MUC1 proteolytic cleavage sites in vivo | Q40807638 | ||
| Purification and composition of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lacto-N-fucopentaose II (CA 19-9). | Q44366720 | ||
| Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin | Q73300727 | ||
| Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin | Q73735409 | ||
| Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells | Q80853556 | ||
| Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis | Q81753531 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 44 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 31842-31852 | |
| P577 | publication date | 2013-09-17 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth | |
| P478 | volume | 288 |
| Q37581540 | Altered tumor-cell glycosylation promotes metastasis |
| Q36283550 | Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy |
| Q38285397 | Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense |
| Q101226457 | Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype |
| Q51730575 | Cell-based glycan arrays for probing glycan-glycan binding protein interactions. |
| Q35612914 | Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis. |
| Q34314456 | Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer |
| Q36167300 | GABA selectively increases mucin-1 expression in isolated pig jejunum |
| Q47552397 | Implication of Soluble Forms of Cell Adhesion Molecules in Infectious Disease and Tumor: Insights from Transgenic Animal Models |
| Q34580364 | Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs. |
| Q58580439 | MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells |
| Q34737810 | MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells |
| Q38177983 | MUC1: a novel metabolic master regulator |
| Q37578540 | Making Home Sweet and Sturdy: Toxoplasma gondii ppGalNAc-Ts Glycosylate in Hierarchical Order and Confer Cyst Wall Rigidity |
| Q57107715 | O-linked mucin-type glycosylation in breast cancer |
| Q36328299 | Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets |
| Q38676224 | Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression |
| Q55318147 | Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics. |
| Q48149385 | Siglec-9 is upregulated in rheumatoid arthritis and suppresses collagen-induced arthritis through reciprocal regulation of Th17-/Treg-cell differentiation. |
| Q92730933 | The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer |
| Q93167129 | The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression |
| Q37600827 | The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. |
| Q38598881 | Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches. |
| Q38602821 | Transmembrane Mucin Expression and Function in Embryo Implantation and Placentation |
| Q55374172 | Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape. |
| Q89736315 | Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function |
| Q39160967 | Viewing Siglecs through the lens of tumor immunology |
Search more.